inflammation caused News
-
Predicting the inflammatory potential of nanoparticles
New methods to screen nanoparticles for potential toxicity to humans are needed to test the growing number of engineered nanoparticles being developed. A battery of simple tests has been developed that can be used to investigate the potential of nanoparticles to cause lung inflammation and also avoids the need for animal testing. Despite the many benefits of using nanomaterials, concerns have ...
-
The feasibility of using vMap in patients after COVID-19 Infection presented at THRS 2021.
COVID-19 is associated with myocardial inflammation which may cause or exacerbate arrhythmias. A study led by Dr. David Krummen was presented at the Taiwan Heart Rhythm Society - Cutting-Edge Care for Heart Rhythm on April 17-18, 2021. The study reports that use of vMap™ computational 12-lead ECG analysis was able to provide arrhythmia insights beyond those available from a standard ...
-
Notitia Biotechnologies company announces expansion of study population for Covid-19 phase 2 study (COVGUT20) for NBT-NM108
After months of preparation, Notitia Biotechnologies Company (Notitia) announced that its COVID-19 Phase 2 study (COVGUT20) for NBT-NM108 has been given support by the Food and Drug Administration (FDA) to expand its study population to all symptomatic COVID-19 patients. "Previously, our trial focused on COVID-19 patients with type 2 diabetes and prediabetes. Now with this timely expansion to ...
-
Bilirubin, which eliminates inflammation... Bilix, the world`s first drug
Discovered in the 1930s... fail every time Chemicalized by combining with hydrophilic substances “To develop a treatment for reperfusion injury” Since the 1930s, 'bilirubin', which causes jaundice in humans, has been in the limelight as an anti-inflammatory substance. The phenomenon in which rheumatoid arthritis patients get jaundice causes rheumatoid inflammation to disappear when ...
-
LISCure`s Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA
LB-P8, a novel drug being developed by LISCure Biosciences, Inc. (LISCure) as a treatment for Primary Sclerosing Cholangitis (PSC), has been designated as an orphan drug by the US FDA. On December 1, 2022, the US FDA notified LISCure of the orphan drug designation of LB-P8, LISCure's microbiome novel drug, as treatment of PSC. LB-P8 is, to the best of company's knowledge, the first drug to be ...
-
Neurent Medical`s RF-based Minimally Invasive Rhinitis Therapy Earns Acclaim from Frost & Sullivan
Neurent Medical's rhinitis device delivers radio frequency energy in a focused and controllable zone of effect, causing minimal collateral damage to surrounding tissues LONDON, Nov. 13, 2018 /CNW/ -- Based on its recent analysis of the European rhinitis therapy market, Frost & Sullivan recognises Neurent Medical with the 2018 European New Product Innovation Award for developing a ...
-
Identifying Asthma Triggers and Managing the Condition in the Nation’s Schools
In 2013, students missed 13.8 million school days due to asthma, making the disease a leading cause of school absenteeism according to the Centers for Disease Control and Prevention (CDC). As recently as 2015, the agency reports that 1 in 12 children had asthma. Asthma is a long-term, inflammatory disease that causes the airways of the lungs to tighten and constrict, leading to wheezing, ...
-
24 Aug 2010: atrazine causes prostate inflammation in male rats and delays puberty
A new study shows that male rats prenatally exposed to low doses of atrazine, a widely used herbicide, are more likely to develop prostate inflammation and to go through puberty later than non-exposed animals. The research adds to a growing body of literature on atrazine, a herbicide predominantly used to control weeds and grasses in crops such as corn and sugar cane. Atrazine and its byproducts ...
-
Lilly`s Mirikizumab Helps Patients Achieve Clinical Remission and Improves Symptoms in Adults with Ulcerative Colitis in 12-Week Phase 3 Induction Study
Eli Lilly and Company (NYSE: LLY) announced today that mirikizumab met the primary and all key secondary endpoints in LUCENT-1, a 12-week Phase 3 induction study evaluating the efficacy and safety of mirikizumab for the treatment of patients with moderate to severe ulcerative colitis (UC). LUCENT-2, a multicenter, randomized, double-blind, placebo-controlled maintenance study of mirikizumab in ...
-
Diesel Exhaust + Cholesterol = Cardiovascular Disease
LOS ANGELES, California, July 26, 2007 (ENS) - Exposure to a combination of diesel exhaust and high blood cholesterol increases the risk for heart attack and stroke far more than exposure to either factor alone, new research reveals. The results indicate that controlling air pollution may prove to be a powerful tool for preventing cardiovascular disease. Published in today's edition of the ...
-
Whooping Cough Hits Pennsylvania School
Recently, another student has reportedly come down with pertussis, also known as whooping cough, at a Montgomery County school in Pennsylvania. The school sent letters home to parents notifying them of the disease and parents have been encouraged to monitor their children for any signs of the illness. Pertussis is a respiratory illness and is a very contagious disease caused by a type of ...
-
Discovery of an anti-inflammatory molecule produced by gut bacteria
Researchers at INRA, INSERM, AP-HP, and UPMC have just discovered a new protein with anti-inflammatory properties, which has been named MAM (microbial anti-inflammatory molecule). It is secreted by the bacterium Faecalibacterium prausnitzii and helps fight intestinal inflammation. This discovery, recently published in the journal Gut, is a major advance in efforts to develop new means of treating ...
-
Childhood obesity linked to traffic pollution
Traffic pollution contributes to childhood obesity, a recent study concludes. In the US investigation of over 4 500 children, the researchers estimated that air pollution increased the body mass index (BMI) of 10-year olds in the most polluted areas of study by 0.4 units, compared to those in the least polluted areas. It is thought that pollution may have slowed the children’s metabolism. ...
-
Almost 5 Million Californians Suffer from Asthma
Last month an article posted by Time reported that 4.9 million people in California suffer from asthma. According to research from the UCLA Center for Health Policy Research the condition disproportionately affects low income residents. The article also states that between 2001 and 2007 there was a 13% overall increase in the asthma rate. The report revealed that Fresno, a lower income inland ...
-
Exposure Risks Associated with Isocyanates & Occupational Asthma Discussed in New Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production discusses exposure risks and occupational asthma due to a family of chemicals known as isocyanates. Isocyanates are powerful irritants to the mucous membranes of the eyes and gastrointestinal and respiratory tracts. Direct skin contact can also cause marked ...
-
XPhyto Signs Letter of Intent for US Manufacturing and Strategic Business Opportunities
XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report that it has signed a non-binding Letter of Intent (“LOI”) to identify and assess potential business synergies for manufacturing, import/export, distribution and product development with a US-based thin film manufacturing firm (the “Firm”). ...
-
Traffic pollution associated with risk of developing type 2 diabetes
Long-term exposure to traffic-related air particle pollution is linked with type 2 diabetes, a new study in Germany has found. Furthermore, the study found that people living close to busy roads were at greater risk of developing the disease than those living further away. Air pollution has been linked to a number of health problems, including heart, circulatory and lung diseases. It has also ...
-
Evolve BioSystems, Inc. Announces the Use of Activated B. infantis EVC001 by International Consortium to Study the Prevention of Type 1 Diabetes in Children
Evolve BioSystems, Inc. today announces that its product, activated B. infantis EVC001, will be used in one of the largest international clinical studies on preventing type 1 diabetes (T1D) in genetically predisposed children. The randomized, controlled, double-blind, multicenter trial will be conducted across eight major research centers in five European countries. The Leona M. and Harry B. ...
-
Neurent Medical Receives FDA Clearance for NEUROMARK, a Novel Multi-Point Nerve Disruption Treatment for Chronic Rhinitis
GALWAY, Ireland–Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced Food and Drug Administration (FDA) clearance of its proprietary NEUROMARK™ Rhinitis Neurolysis Therapy™ (RNT). The clearance gives clinicians access to an in-office treatment designed to create lesions to disrupt the posterior nasal nerves, ...
-
New Study Finds C. diff on a High Percentage of Healthcare Workers’ Hands
A new study has been published in the current issue of Infection Control and Hospital Epidemiology that found that almost a quarter of healthcare workers’ hands had Clostridium difficile (C. diff) spores on them following routine care of patients known to have the bacteria. This surprising figure brings to light the need to educate healthcare providers and the public about how this ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you